vaginose

A phase-3, double-blind, placebo-controlled study of the effectiveness and safety of single oral doses of secnidazole 2 g for the treatment of women with bacterial vaginosis

Revue : American Journal of Obstetrics & Gynecology, December 2017, Volume 217, Issue 6, Pages 678.e1–678.e9 Auteurs : Jane R. Schwebke, Franklin G. Morgan Jr., William Koltun, Paul Nyirjesy DOI : 10.1016/j.ajog.2017.08.017

Copyright 2013 © Conseil de l'Ordre des sages-femmes des bouches du Rhône